Companies: 10,795·Total market cap: $144.5T
Ovid Therapeutics Inc.

Ovid Therapeutics Inc.

OVIDNASDAQHealthcare● Active
$2.36
$-0.04(-1.67%)
Market Cap$311247347
P/E Ratio—
52W High$3.105
52W Low$0.272
SEC Filings

Ovid Therapeutics Inc. (OVID) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001636651 · OVID · NASDAQ · as of Jun 9, 2026

Filing snapshot

515
Total Filings
8-K
Latest Form
2026-06-03
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001636651 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-18
Fiscal Year End
Mar 18, 2026
Accession No.
0001628280-26-019438
Primary Document
ovid-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001636651 · Accession 0001628280-26-019438

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-03Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
10-QQuarterly Report
10-Q
2026-05-12
View
8-KCurrent Report
8-K
2026-05-12
View
ARSARS
ARS
2026-04-27
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-27
View
DEF 14AProxy Statement
DEF 14A
2026-04-27
View
424B3424B3
424B3
2026-04-27
View
EFFECTEFFECT
EFFECT
2026-04-24
View
CORRESPCORRESP
CORRESP
2026-04-23
View
Showing 1–15 of 356 filingsForm 4 / 144 hidden· 515 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001636651  |  Exchange: NASDAQ · Healthcare

Ovid Therapeutics Inc. (NASDAQ: OVID) has submitted 515 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001636651, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Ovid Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Ovid Therapeutics Inc. 10-K was filed on 2026-03-18 for fiscal year ending 2026. Historical OVID 10-K annual reports are available from 2015 through 2026.

Investors researching Ovid Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
MGNX SEC Filings →WHWK SEC Filings →STTK SEC Filings →CNTX SEC Filings →ORMP SEC Filings →CNTB SEC Filings →IFRX SEC Filings →KLRS SEC Filings →
→ OVID Financials→ OVID Earnings→ OVID Insider Trades

Frequently Asked Questions

OVID SEC Filings · 8 questions

Ovid Therapeutics Inc. (OVID) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 515 filings and access original documents at no cost. Ovid Therapeutics Inc.'s CIK is 0001636651.

OVID SEC filingsOvid Therapeutics Inc. SEC documentsfind OVID 10-K